Editor's Choice
|
CVS Declines Coverage for Breakthrough HIV Drug25 Aug 2025
CVS Health’s Coverage Decision The owner of America’s largest pharmacy benefit manager (PBM) has made a controversial decision to decline... Continue Reading
|
|
FDA Approves Dawnzera for HAE Treatment25 Aug 2025
Introduction to Dawnzera’s FDA Approval The FDA has approved Dawnzera (donidalorsen), marking a significant milestone in hereditary angioedema (HAE) treatment.... Continue Reading
|
|
TruBridge | Streamlining Healthcare Solutions for Future Growth01 Mar 2024
CPSI, now TruBridge, Inc., has rebranded to streamline healthcare solutions, enhance market presence, and foster future growth. This unified approach... Continue Reading
|
|
Sentara Health Innovates with AI for Clinicians01 Mar 2024
Sentara Health partners with RhythmX AI to develop AI-driven support for clinicians, aiming to revolutionize primary care. By leveraging advanced... Continue Reading
|
|
Empowering Omics Analysis | Gnome Meets Playground01 Mar 2024
Almaden Genomics and BigOmics collaborate to merge g.nome® with Omics Playground, providing seamless omics data analysis. This integration facilitates end-to-end... Continue Reading
|
|
Fabric’s $60M Boost to Healthcare Automation Revolution01 Mar 2024
Fabric secures $60M in Series A funding led by General Catalyst to advance its AI-driven healthcare platform. With a focus... Continue Reading
|
|
Healthcare Revolution | AI Enhances Customer Insights Dramatically01 Mar 2024
Authenticx unveils a groundbreaking AI solution for healthcare customer insights. Their GenAI tool leverages a 7-billion parameter language model to... Continue Reading
|
|
CitiusTech Launches Generative AI Quality & Trust Solution23 Feb 2024
CitiusTech introduces a pioneering solution to enhance trust and reliability in Generative AI (Gen AI) for healthcare. Addressing concerns of... Continue Reading
|
|
Health Systems Grapple with AI Governance: Balancing Promise and Risk23 Feb 2024
A survey highlights the limited presence of formal AI governance policies in healthcare systems, particularly concerning generative AI. Despite this,... Continue Reading
|
|
Cancer and Neuroscience Led 2023 VC, M&A Investment in Biopharma23 Feb 2024
J.P. Morgan’s 2023 Annual Biopharma Licensing and Venture Report indicates a downturn in biopharma investment last year, particularly evident in... Continue Reading
|









